Squamous Cell Carcinoma of Esophagus

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-02-11
Clinical Trial Update: A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus [Phase 2]
This document provides a clinical trial update on a Phase II study of Afatinib in metastatic or recurrent squamous cell carcinoma of the eso…